Dear Anna
Thank you for your email.   
Companies which wish to run a clinical trial on a medicine which has been
approved in New Zealand do not have to obtain Medsafe approval or inform
Medsafe before they start their trial.  As Comirnaty is approved in New
Zealand I am unaware of any trials which are being conducted using
Comirnaty.  
The WHO has a Vaccine Tracker with link to trials are been or have been
run -
[1]https://www.who.int/publications/m/item/...
You can also search on the NZ/Australia clinical trial registry
[2]https://www.anzctr.org.au/- and the US registry
- [3]https://clinicaltrials.gov/
I hope this is of help
Kind regads
Becci

[4]ANZCTR
COVID-19 studies are our top priority. For all other studies, we recommend
commencing the registration process concurrently with your ethics
submission and allowing at least 8 weeks for registration to be completed
from date of first submission as we are experiencing 4 week turn-around
time in review of submissions and resubmissions.
www.anzctr.org.au

[5][IMG] [6]Home - ClinicalTrials.gov
ClinicalTrials.gov is a resource provided by the U.S. National
Library of Medicine. IMPORTANT: Listing a study does not mean it
has been evaluated by the U.S. Federal Government.Read our
disclaimer for details.. Before participating in a study, talk to
your health care provider and learn about the risks and potential
benefits.
clinicaltrials.gov

------------------------------------------------------------------------

From: Anna McAfee <[7][FOI #16486 email]>
Sent: Tuesday, 24 August 2021 10:38
To: OIA Requests <[8][email address]>
Subject: Official Information request - Regarding the MOH management of
the "Covid 19 Comirnaty" study groups

 

Dear Ministry of Health,

Regarding the Pfizer Covid- 19 Comirnaty trial.

Please provide information and documentation regarding the process/s you
are using to ensure the validity of the clinical trial;

1/ How are trial participants being followed up with, and how often?

2/ How many New Zealanders are the MOH planning on having in the control
group, to ensure a valid study?

2/ How often are trial participants being contacted, to ensure that any
ADR's are reported to CARM?

3/ What makers are in place as far as adverse reactions, or deaths, that
would see the study paused or stopped?

4/ What statements are being made in the informed consent process, that
ensure that all participants are fully aware that;
a) This intervention is in a clinical trial/ experimental phase.
b) This treatment has known and documented risks, known fatalities
associated with administration and unknown risks in the long term. 
c) This treatment does not prevent participants from contracting the
virus, or transmitting it to others within their community.

Yours faithfully,

Anna McAfee

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[9][FOI #16486 email]

Is [10][Ministry of Health request email] the wrong address for Official Information
requests to Ministry of Health? If so, please contact us using this form:
[11]https://scanmail.trustwave.com/?c=15517&...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[12]https://scanmail.trustwave.com/?c=15517&...

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

-------------------------------------------------------------------

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. https://www.who.int/publications/m/item/...
2. https://www.anzctr.org.au/
3. https://clinicaltrials.gov/
4. https://www.anzctr.org.au/
5. https://clinicaltrials.gov/
6. https://clinicaltrials.gov/
7. mailto:[FOI #16486 email]
8. mailto:[email address]
9. mailto:[FOI #16486 email]
10. mailto:[Ministry of Health request email]
11. https://scanmail.trustwave.com/?c=15517&...
12. https://scanmail.trustwave.com/?c=15517&...

hide quoted sections